USGA Approves OnCore's Hollow-Metal Core Golf Ball BUFFALO,

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
USGA Approves OnCore's Hollow-Metal Core Golf Ball

BUFFALO, N.Y., Oct. 23, 2013 (GLOBE NEWSWIRE) -- For over thirty-five years the rules of the USGA have been largely unchanged when it comes to the specific characteristics governing golf ball technology and performance. While clubs have undergone significant changes during that period, the basic elements of golf ball construction have stayed fairly constant. However, on October 15, 2013, the USGA notified OnCore Golf that "Golf balls with rigid cores whose core diameters do not exceed 0.9 inches, such as the OnCore Evo Ball, will be permitted exceptions to the "traditional and customary form and make" requirement in Rule 1 of Appendix III." As a result of this new interpretation, OnCore's EVO ball was tested and found to be conforming to the Rules of Golf. It will appear on the list of conforming equipment which will next be updated on November 6th.

Industry thought-leaders have described the introduction of a hollow metal core as ".. a milestone in the history of golf and for the golf ball in particular.." The golf ball community now has the ability to consider and incorporate an entirely new approach to golf ball construction - leading to a wider variety of golf balls that can be tailored for players of all skill levels while remaining true to the Rules of Golf.

"We are thrilled with the USGA's determination that rigid cores such as the OnCore hollow metal-core, will be permissible in designing the golf balls of the future. We have had an enthusiastic reaction to our ball from players of all skill levels. Our objective has always been to help golfers have a better experience and get more enjoyment from the game," stated Bret Blakely, OnCore's President. "We expect that OnCore's products and technology which are exclusively secured by three U.S. patents will soon become the trendsetters in the industry."

One of our dreams is to have young, up and coming tour players using our equipment. With the USGA approval, this dream can become reality, which is really exciting for us." stated Steve Coulton, Vice President. "To accelerate that objective and provide OnCore with the financial resources needed to execute our plan, we've now established a partnership with SeedInvest - one of the leading equity-based, crowdfunding platforms connecting accredited investors to high-quality start-ups seeking funding. We encourage fans of the company and ball who might be interested in investing in OnCore to visit www.seedinvest.com/oncore.golf ."
 
About OnCore Golf ( www.oncoregolf.com ) is a dynamic and innovated golf ball company led by two young entrepreneurs in their early 30s, Bret Blakely and Steve Coulton. The company is headquartered in Buffalo, NY and is dedicated to improving the lives, scores, and enjoyment of golfers of all skill levels by offering exciting products that live up to the company's tagline - "You Just Became a Better Golfer."

Photos accompanying this release are available at:
http://www.globenewswire.com/newsroom/prs/?pkgid=21738

Curt Rogers Director of Public Relations 716.860.2331

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

Updated Category News Views 29

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Continue Reading
Pacira BioSciences Faces Shareholder Revolt in M&A Deal

Updated Category News Views 4

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Continue Reading
AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

Updated Category News Views 28

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Continue Reading
2026 Community Impact Week: Slam Dunk for Community Unity

Updated Category News Views 24

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Continue Reading
Duolingo Faces Lawsuit Over Alleged Investor Missteps

Updated Category News Views 35

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

Continue Reading
LEGO Mashes Star Wars and Marvel for Fans' Delight

Updated Category News Views 30

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Continue Reading
Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Updated Category News Views 20

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Continue Reading

Top 5 Most Recently Viewed Articles

Endava Investors: Legal Action Could Recover Your Losses

Updated Category News Views 87

Endava got tangled in a class action lawsuit over securities fraud back in 2024. Investors were already feeling the squeeze as whispers about declining demand for its services echoed through the trading floor. You know how it goes—when rumors hit, shares take a dive faster than you can blink. Class Action Reality: Who Gets to Play? The lawsuit targeted shareholders who...

Continue Reading
New Mortgage Ratings Assigned to Deephaven Trust Portfolio

Updated Category News Views 177

Introduction to Deephaven Residential Mortgage Trust 2024-1 In an important development within the non-prime mortgage market, KBRA has recently assigned preliminary ratings to eight classes of mortgage-backed notes from Deephaven Residential Mortgage Trust 2024-1 (DRMT 2024-1). This $514.6 million transaction comprises a unique pool of 1,330 residential mortgages,...

Continue Reading
Meta Platforms Declares Cash Dividend for Shareholders

Updated Category News Views 325

Quarterly Cash Dividend Announcement from Meta Platforms The board of directors of Meta Platforms, Inc. (NASDAQ: META) has recently declared a quarterly cash dividend of $0.525 per share, benefitting shareholders holding both Class A and Class B common stock. This dividend reflects the company's ongoing commitment to returning value to its shareholders. Dividend Payment...

Continue Reading
Campine Expects Strong Financial Upsurge in 2024 Performance

Updated Category News Views 125

Campine NV Forecasts Impressive Growth in 2024 Campine NV, a well-known name in the metals recycling and specialty chemicals sector, is gearing up for a promising financial year ahead. The company has recently indicated that it anticipates higher profits in 2024, thanks to favorable market conditions. Projected Revenue Growth for 2024 According to Campine's expectations,...

Continue Reading
Thumzup Media's Strategic Investment in Dogecoin Ahead of ETFs

Updated Category News Views 147

Thumzup Media's Strategic Move into Dogecoin Thumzup Media Corporation (Nasdaq: TZUP) has made headlines with its latest purchase of Dogecoin, securing around 7.5 million tokens valued at approximately $2 million. This significant acquisition marks the company's first open-market investment in Dogecoin, reflecting a strong belief in the digital currency's potential for...

Continue Reading